A comparison of cost-effectiveness between doxycycline and azithromycin with topical clindamycin in the treatment of patients with moderate to severe acne vulgaris: Prospective, randomized study

Apoorva; Girish K; Amoolya D

doi:10.5455/njppp.2020.10.02038202013022020

2026, Vol: 16, Issue: 1

16 / 1Current Issue Online First Archive Aims and Scope Abstracting & Indexing Most Accessed Articles Most Downloaded Articles Most Cited Articles

Required files to be uploaded

NJPPP Manuscript Submission Form
Title Page

Original Research
Online Published: 26 Feb 2020

Natl J Physiol Pharm Pharmacol. 2020; 10(4): 279-284

doi: 10.5455/njppp.2020.10.02038202013022020

A comparison of cost-effectiveness between doxycycline and azithromycin with topical clindamycin in the treatment of patients with moderate to severe acne vulgaris: Prospective, randomized study

Apoorva, Girish K, Amoolya D.

Cited By:1

Abstract
Background: Acne vulgaris is one of the chronic, common dermatological skin diseases with inflammatory lesions, prevalent among adolescents. The management of acne vulgaris is primarily pharmacotherapy comprising both topical and systemic anti-inflammatory and antimicrobials agents.

Aims and Objective: Pharmacoeconomic analysis is now an integral part of therapy. There are several studies regarding recommendations, guidelines, efficacy, tolerability, and outcomes of therapies used in acne vulgaris; but hardly any studies comparing the cost-effectiveness of this combination of topical and oral antimicrobials in the treatment of moderate to severe acne vulgaris in our country; hence, this study was taken up to provide useful and valid data.

Materials and Methods: This was a randomized, open-label, active-controlled, comparative study of cost-effectiveness analysis of doxycycline and azithromycin in 60 subjects, who gave written informed consent and had moderate to severe acne vulgaris. Azithromycin was given as pulse therapy whereas doxycycline was given once daily with topical clindamycin twice daily for 8 weeks in both groups. Direct and indirect medical costs were considered, average cost-effectiveness ratio (ACER) and cost-effective analysis (CEA) were analyzed. Non-parametric test like MannWhitney test was used to access the efficacy of the drugs and the result was statistically significant. Results were depicted in the form of tables, figures, and graphs.

Results: The ACER and CEA showed that azithromycin was better than doxycycline.

Conclusion: The study drugs were effective in reducing the lesion count but required long-term treatment; however, azithromycin was more cost-effective than doxycycline.

Key words: Acne Vulgaris; Azithromycin; Cost-effective Analysis; Doxycycline

	ARTICLE TOOLS
	Abstract
	PDF Fulltext
	How to cite this article
	Citation Tools
	Related Records
	Articles by Apoorva Articles by Girish K Articles by Amoolya D
	on Google
	on Google Scholar

How to Cite this Article

Pubmed Style

Apoorva, K G, D A. A comparison of cost-effectiveness between doxycycline and azithromycin with topical clindamycin in the treatment of patients with moderate to severe acne vulgaris: Prospective, randomized study. Natl J Physiol Pharm Pharmacol. 2020; 10(4): 279-284. doi:10.5455/njppp.2020.10.02038202013022020

Web Style

Apoorva, K G, D A. A comparison of cost-effectiveness between doxycycline and azithromycin with topical clindamycin in the treatment of patients with moderate to severe acne vulgaris: Prospective, randomized study. https://www.njppp.com/?mno=85953 [Access: June 22, 2026]. doi:10.5455/njppp.2020.10.02038202013022020

AMA (American Medical Association) Style

Apoorva, K G, D A. A comparison of cost-effectiveness between doxycycline and azithromycin with topical clindamycin in the treatment of patients with moderate to severe acne vulgaris: Prospective, randomized study. Natl J Physiol Pharm Pharmacol. 2020; 10(4): 279-284. doi:10.5455/njppp.2020.10.02038202013022020

Vancouver/ICMJE Style

Apoorva, K G, D A. A comparison of cost-effectiveness between doxycycline and azithromycin with topical clindamycin in the treatment of patients with moderate to severe acne vulgaris: Prospective, randomized study. Natl J Physiol Pharm Pharmacol. (2020), [cited June 22, 2026]; 10(4): 279-284. doi:10.5455/njppp.2020.10.02038202013022020

Harvard Style

Apoorva, K, . G. & D, . A. (2020) A comparison of cost-effectiveness between doxycycline and azithromycin with topical clindamycin in the treatment of patients with moderate to severe acne vulgaris: Prospective, randomized study. Natl J Physiol Pharm Pharmacol, 10 (4), 279-284. doi:10.5455/njppp.2020.10.02038202013022020

Turabian Style

Apoorva, Girish K, and Amoolya D. 2020. A comparison of cost-effectiveness between doxycycline and azithromycin with topical clindamycin in the treatment of patients with moderate to severe acne vulgaris: Prospective, randomized study. National Journal of Physiology, Pharmacy and Pharmacology, 10 (4), 279-284. doi:10.5455/njppp.2020.10.02038202013022020

Chicago Style

Apoorva, Girish K, and Amoolya D. "A comparison of cost-effectiveness between doxycycline and azithromycin with topical clindamycin in the treatment of patients with moderate to severe acne vulgaris: Prospective, randomized study." National Journal of Physiology, Pharmacy and Pharmacology 10 (2020), 279-284. doi:10.5455/njppp.2020.10.02038202013022020

MLA (The Modern Language Association) Style

Apoorva, Girish K, and Amoolya D. "A comparison of cost-effectiveness between doxycycline and azithromycin with topical clindamycin in the treatment of patients with moderate to severe acne vulgaris: Prospective, randomized study." National Journal of Physiology, Pharmacy and Pharmacology 10.4 (2020), 279-284. Print. doi:10.5455/njppp.2020.10.02038202013022020

APA (American Psychological Association) Style

Apoorva, K, . G. & D, . A. (2020) A comparison of cost-effectiveness between doxycycline and azithromycin with topical clindamycin in the treatment of patients with moderate to severe acne vulgaris: Prospective, randomized study. National Journal of Physiology, Pharmacy and Pharmacology, 10 (4), 279-284. doi:10.5455/njppp.2020.10.02038202013022020

About National Journal of Physiology, Pharmacy and Pharmacology

Contact Information

How to cite this article